A detailed history of Keudell transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Keudell holds 2,245 shares of DGX stock, worth $307,767. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,245
Previous 2,312 2.9%
Holding current value
$307,767
Previous $316,000 2.85%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$137.09 - $137.09 $9,185 - $9,185
-67 Reduced 2.9%
2,245 $307,000
Q1 2024

May 07, 2024

BUY
$123.78 - $142.11 $10,521 - $12,079
85 Added 3.82%
2,312 $307,000
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $6,272 - $7,338
52 Added 2.39%
2,227 $307,000
Q1 2023

Apr 18, 2023

SELL
$131.53 - $155.76 $2,893 - $3,426
-22 Reduced 1.0%
2,175 $307,000
Q3 2022

Oct 12, 2022

SELL
$121.77 - $141.1 $243 - $282
-2 Reduced 0.09%
2,197 $270,000
Q4 2021

Feb 08, 2022

SELL
$140.36 - $173.01 $12,772 - $15,743
-91 Reduced 3.97%
2,199 $380,000
Q2 2021

Jul 13, 2021

BUY
$126.66 - $141.48 $1,266 - $1,414
10 Added 0.44%
2,290 $302,000
Q1 2021

Apr 13, 2021

SELL
$114.63 - $133.34 $5,846 - $6,800
-51 Reduced 2.19%
2,280 $293,000
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $5,184 - $5,890
-46 Reduced 1.94%
2,331 $278,000
Q2 2020

Jul 14, 2020

BUY
$73.34 - $122.61 $174,329 - $291,443
2,377 New
2,377 $271,000
Q1 2020

Apr 20, 2020

SELL
$75.14 - $115.68 $173,122 - $266,526
-2,304 Closed
0 $0
Q2 2019

Aug 23, 2019

BUY
$85.18 - $101.94 $196,254 - $234,869
2,304 New
2,304 $230,000
Q2 2019

Aug 21, 2019

SELL
$85.18 - $101.94 $193,273 - $231,301
-2,269 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$80.68 - $89.92 $183,062 - $204,028
2,269 New
2,269 $204,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.